Corentec Co

Corentec Co Operating Cash Flow

The Operating Cash Flow of Corentec Co (104540.KQ) as of Oct 29, 2026 is 26.46 B KRW. In the previous year, Operating Cash Flow was -6.61 B KRW — a change of -500.52% (higher).

Operating Cash Flow

26.46 BKRW

YoY

-500.52%

Last updated:

Operating Cash Flow of Corentec Co is 2025 26.46 B KRW. Operating Cash Flow of Corentec Co was 2024 -6.61 B KRW. It decreases by -500.52% higher compared to the previous year.

The Corentec Co Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
5.26 B KRW
Jan 1, 2019
3.86 B KRW
Jan 1, 2020
-3.61 B KRW
Jan 1, 2021
4.08 B KRW
Jan 1, 2022
10.60 B KRW
Jan 1, 2023
2.63 B KRW
Jan 1, 2024
-6.61 B KRW
Jan 1, 2025
26.46 B KRW
The Corentec Co Operating Cash Flow history
YEAROperating Cash FlowYoY
26.46 BKRW-500.52%
-6.61 BKRW-350.76%
2.63 BKRW-75.15%
10.60 BKRW+160.06%
4.08 BKRW-212.97%
-3.61 BKRW-193.58%
3.86 BKRW-26.69%
5.26 BKRW-10.29%
5.86 BKRW+99.26%
2.94 BKRW+15.62%
2.54 BKRW+464.59%
450.70 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co., Ltd. manufactures and sells artificial articulations, including hip, knee, and spine products. The company offers hip products under the BENCOX brand, featuring primary systems, hemi-arthroplasty systems, and revision systems such as cementless femoral stems and acetabular cups. Knee products are sold under the LOSPA brand, including fixed and mobile primary knee systems and revision systems. Spine products also carry the LOSPA IS brand, comprising pedicle screws and peek cages. Corentec distributes these products domestically and internationally, targeting healthcare providers and hospitals that require orthopedic solutions. The firm’s revenue comes from the sale of hip, knee, and spine products through its BENCOX, LOSPA, and LOSPA IS brand portfolios. Domestic and overseas markets are key segments, with the company focusing on orthopedic surgeons and medical institutions that purchase these specialized medical devices. Corentec’s product lines are designed for both primary and revision surgeries, catering to a broad range of orthopedic needs in the healthcare sector. Corentec Co., Ltd. serves healthcare providers globally, with its BENCOX brand dominating hip product sales and LOSPA/LOSPA IS covering knee and spine solutions. The company’s distribution strategy emphasizes direct sales to hospitals and medical centers, ensuring consistent product availability for surgical procedures. By maintaining distinct brand identities for each product category, Corentec efficiently targets specific medical specialties within the orthopedic market. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Operating Cash Flow of Corentec Co is 26.46 B KRW in 2025.

Operating Cash Flow of Corentec Co changed from -6.61 B KRW to 26.46 B KRW, representing a -500.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co